Dr. Walter Dunn is an Assistant Clinical Professor at the Semel Institute for Neuroscience and Human Behavior at UCLA. He is an attending physician in the UCLA Psychosis Clinic and psychiatrist for the UCLA Operation Mend Program. He is the director of the Mood Clinic and Interventional Psychiatry Service at the Greater Los Angeles VA Medical Center. Prior to his medical training, he completed his PhD and post-doctoral work in molecular virology. He also served in the United States Marines and has found that experience to be invaluable in working with veterans. His research is focused on using non-invasive neuromoduation to target auditory processing deficits in patients with schizophrenia. His published work suggests that direct current stimulation may improve auditory processing in schizophrenia patients, which may have implications in improving social cognition and functioning. In his clinical work, he uses transcranial magnetic stimulation, ketamine, and ECT, and treats patients with bipolar disorder, schizophrenia, and treatment resistant depression.
He serves on the scientific committee and executive committee of the International Society for CNS Clinical Trials Methodology. He is currently an advisor to the FDA as a member of the FDA’s Psychopharmacologic Drug Advisory Committee.
To contact GME, email us at [email protected]